Clinical trials
Phase 2 Purpura, Thrombocytopenic, Idiopathic trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Baxalta now part of Shire | 1 |
| GlaxoSmithKline | 1 |
| Kezar Life Sciences, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Oscotec Inc. | 1 |
| Pfizer | 1 |
| Symphogen A/S | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 9 |
| Anemia | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Hematologic Diseases | 1 |
| Hemolysis | 1 |
| Purpura | 1 |
| Thrombocytopenia | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.